154 related articles for article (PubMed ID: 18206365)
1. Are the progestins responsible for breast cancer risk during hormone therapy in the postmenopause? Experimental vs. clinical data.
Seeger H; Mueck AO
J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):11-5. PubMed ID: 18206365
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer risk during hormone therapy: experimental versus clinical data.
Ruan X; Seeger H; Mueck AO
Minerva Endocrinol; 2012 Mar; 37(1):59-74. PubMed ID: 22382615
[TBL] [Abstract][Full Text] [Related]
3. The Women's Health Initiative trial and related studies: 10 years later: a clinician's view.
Gurney EP; Nachtigall MJ; Nachtigall LE; Naftolin F
J Steroid Biochem Mol Biol; 2014 Jul; 142():4-11. PubMed ID: 24172877
[TBL] [Abstract][Full Text] [Related]
4. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.
van Leeuwen FE
Acta Endocrinol (Copenh); 1991; 125 Suppl 1():13-26. PubMed ID: 1801500
[TBL] [Abstract][Full Text] [Related]
5. Recent epidemiological evidence relevant to the clinical management of the menopause.
Shapiro S
Climacteric; 2007 Oct; 10 Suppl 2():2-15. PubMed ID: 17882666
[TBL] [Abstract][Full Text] [Related]
6. [Effects of progesterone and progestational hormones on the mammary gland].
Gorins A; Denis C
Arch Anat Cytol Pathol; 1995; 43(1-2):28-35. PubMed ID: 7794024
[TBL] [Abstract][Full Text] [Related]
7. Are progestins really necessary as part of a combined HRT regimen?
Sturdee DW
Climacteric; 2013 Aug; 16 Suppl 1():79-84. PubMed ID: 23651281
[TBL] [Abstract][Full Text] [Related]
8. Comparative cardiovascular effects of different progestins in menopause.
Rosano GM; Fini M
Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
[TBL] [Abstract][Full Text] [Related]
9. Progesterone vs. synthetic progestins and the risk of breast cancer: a systematic review and meta-analysis.
Asi N; Mohammed K; Haydour Q; Gionfriddo MR; Vargas OL; Prokop LJ; Faubion SS; Murad MH
Syst Rev; 2016 Jul; 5(1):121. PubMed ID: 27456847
[TBL] [Abstract][Full Text] [Related]
10. Postmenopausal hormone therapy: cardiovascular risks.
Prescrire Int; 2003 Apr; 12(64):65-9. PubMed ID: 12674130
[TBL] [Abstract][Full Text] [Related]
11. Possible role of PGRMC1 in breast cancer development.
Neubauer H; Ma Q; Zhou J; Yu Q; Ruan X; Seeger H; Fehm T; Mueck AO
Climacteric; 2013 Oct; 16(5):509-13. PubMed ID: 23758160
[TBL] [Abstract][Full Text] [Related]
12. Links between hormone replacement therapy and neoplasia.
Hulka BS
Fertil Steril; 1994 Dec; 62(6 Suppl 2):168S-175S. PubMed ID: 7958013
[TBL] [Abstract][Full Text] [Related]
13. Hormone replacement therapy and cancer.
Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
[TBL] [Abstract][Full Text] [Related]
14. Hormone replacement therapy and breast cancer risk in Kyushu University Hospital: supporting the Women's Health Initiative study.
Nozaki M; Koera K; Nagata H; Nakano H
J Obstet Gynaecol Res; 2004 Aug; 30(4):297-302. PubMed ID: 15238106
[TBL] [Abstract][Full Text] [Related]
15. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
Menendez JA; Oza BP; Colomer R; Lupu R
Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
[TBL] [Abstract][Full Text] [Related]
16. Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin.
Anderson GL; Chlebowski RT; Rossouw JE; Rodabough RJ; McTiernan A; Margolis KL; Aggerwal A; David Curb J; Hendrix SL; Allan Hubbell F; Khandekar J; Lane DS; Lasser N; Lopez AM; Potter J; Ritenbaugh C
Maturitas; 2006 Sep; 55(2):103-15. PubMed ID: 16815651
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer: the role of hormone therapy.
Creasman WT
Semin Reprod Med; 2005 May; 23(2):167-71. PubMed ID: 15852202
[TBL] [Abstract][Full Text] [Related]
18. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
Colditz GA; Hankinson SE; Hunter DJ; Willett WC; Manson JE; Stampfer MJ; Hennekens C; Rosner B; Speizer FE
N Engl J Med; 1995 Jun; 332(24):1589-93. PubMed ID: 7753136
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer risk with postmenopausal hormonal treatment.
Collins JA; Blake JM; Crosignani PG
Hum Reprod Update; 2005; 11(6):545-60. PubMed ID: 16150813
[TBL] [Abstract][Full Text] [Related]
20. Hormone replacement therapy and risk of breast cancer: the role of progestins.
Stahlberg C; Pedersen AT; Lynge E; Ottesen B
Acta Obstet Gynecol Scand; 2003 Apr; 82(4):335-44. PubMed ID: 12716318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
